Ultrahuman has raised $17.5m in a Series B financing round for its wearable glucose tracking technology. The India-based company is the developer of Ultrahuman Cyborg – a continuous metabolism tracker designed to help people with diabetes track blood glucose in real-time and optimise their diet and exercise. It utilises biomarkers to tell users how their body reacts to a specific type of food, fuel efficiently for exercise and eat for better sleep. The funds raised will allow Ultrahuman to launch in more countries and improve its life sciences research capabilities.
Meanwhile, a digital health start-up, Breathe Well-being, has raised $5.5m in first-round financing, which it will use to scale up a clinical tool that helps people “prevent, manage and reverse Type 2 diabetes”. The Breathe Well-being programme centres around a gaming-style app that provides personalised advice on daily diet, fitness and stress reduction while tracking steps taken, calories eaten, calories burnt, weight, blood glucose levels, hydration and sleep quality. It also sets goals to improve behaviours alongside a forum to connect with other people with diabetes and access to a personal coach.
